Kankere ea tšoelesa ea senya e bolaea batho ba bakae?
Kankere ea tšoelesa ea senya ke kankere ea bobeli e atileng haholo ho banna lefatšeng ka bophara, ka linyeoe tse ncha tse ka bang limilione tse 1,276 tse tlalehiloeng ka 2018, e emelang 7.1% ea linyeoe tsohle tsa kankere ho banna.
Sekhahla sa lefu la kankere ea tšoelesa ea senya le sona se phahame, ka ho hakanngoa hore ho na le mafu a 37,005 lefatšeng ka bophara ka 2018.
Leha ho le joalo, sekhahla sa ho bolaoa ke kankere ea tšoelesa ea senya se fapana haholo ho ea ka libaka, Afrika Bophirimela e na le kotsi ea bohlano e phahameng ka ho fetisisa ea ho bolaoa ke kankere ea tšoelesa ea senya lefatšeng,'me Nigeria e na le baahi le moruo o moholohali sebakeng sena.
Nigeria, kankere ea tšoelesa ea senya ke kankere e atileng haholo le e bolaeang banna ka ho fetisisa, e nang le linyeoe tse hakanyetsoang ho 32,8 le mafu a 16,3 ho banna ba 100 000.
Sena se feta habeli sekhahla sa ho shoa ha batho Amerika Leboea.
Ho lemoha lefu lena ka mor'a nako, mehloli e fokolang ea ho hlahloba le ho le lemoha, le ho fokotseha ha litokomane le ho tlaleha ha linyeoe ho tlatsetsa ho sekhahla se phahameng sa lefu la Nigeria.
United States, kankere ea tšoelesa ea senya ke sesosa sa bobeli se tloaelehileng ka ho fetisisa sa lefu la kankere ho banna, ka banna ba ka bang 40 000 ba bolaoang ke lefu lena selemo le selemo.
Palo ea batho ba bolaoang ke kankere ea tšoelesa ea senya e fokotsehile butle-butle ho tloha mathoasong a bo-1990, empa e ntse e le bothata bo boholo ba bophelo bo botle.
Ka kakaretso, kankere ea tšoelesa ea senya ke lefu le bolaeang, haholo-holo libakeng tse se nang tlhokomelo ea bongaka le lisebelisoa tse lekaneng tsa ho hlahloba.
Leha ho le joalo, ho lemoha le ho phekola mafu a sa le pele ho ka ntlafatsa liphello tsa' ona haholo' me ha fokotsa sekhahla sa ho shoa ha batho.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
['Tlhokomeliso: tsa bongaka']
["Websaete ena e etselitsoe ho ruta le ho fana ka boitsebiso feela'me ha e fane ka keletso ea bongaka kapa litšebeletso tsa litsebi."]
["Boitsebiso bo fanoeng ha boa lokela ho sebelisoa ho hlahloba kapa ho phekola bothata ba bophelo bo botle kapa lefu,'me ba batlang keletso ea bongaka ba lokela ho buisana le ngaka e nang le lengolo la tumello."]
['Ka kōpo hlokomela hore neural net e hlahisang likarabo lipotsong, ha e nepahale haholo-holo ha ho tluoa linomorong.']
["Kamehla batla keletso ea ngaka ea hao kapa mofani e mong ea tšoanelehang oa tlhokomelo ea bophelo mabapi le boemo ba bongaka. Le ka mohla u se ke ua hlokomoloha keletso ea setsebi sa bongaka kapa ua lieha ho e batla ka lebaka la ntho eo u e balileng websaeteng ena. Haeba u nahana hore u ka 'na ua ba le boemo ba tšohanyetso ba bongaka, letsetsa 911 kapa u ee kamoreng ea tšohanyetso e haufi hang-hang. Ha ho kamano ea ngaka le mokuli e bōptjoang ke websaeteng ena kapa tšebeliso ea eona. BioMedLib kapa basebetsi ba eona, kapa motho leha e le ofe ea tlatsetsang ho websaeteng ena, ha a etse litemoso, tse hlakileng kapa tse sa hlakang, mabapi le boitsebiso bo fanoeng mona kapa tšebeliso ea eona."]
['Tlhokomeliso: litokelo tsa bangoli']
['Molao oa Digital Millennium Copyright Act oa 1998, 17 U.S.C. § 512 (DMCA) o fana ka litokelo tsa beng ba litokelo tsa bangoli ba lumelang hore thepa e hlahang Inthaneteng e hatakela litokelo tsa bona tlasa molao oa litokelo tsa bangoli ba U.S. ']
['Haeba u lumela ka tumelo e ntle hore litaba leha e le life kapa thepa e fumanehang mabapi le websaeteng kapa litšebeletso tsa rona e tlōla litokelo tsa hau tsa molao, uena (kapa moemeli oa hau) a ka re romella tsebiso e kōpang hore litaba kapa thepa e tlosoe, kapa ho fihlella ho eona ho thibeloe. ']
['Ditsebiso di tlameha ho romelwa ka lengolo ka imeile (bona karolo ya "Ho iteanya" bakeng sa aterese ya imeile). ']
["DMCA e hloka hore tsebiso ea hao ea ho tlōla ha molao ho boleloang hore e na le boitsebiso bo latelang: (1) tlhaloso ea mosebetsi o sirelelitsoeng ka molao o boleloang hore o tlōloa; (2) tlhaloso ea litaba tse boleloang hore li tlōla molao le boitsebiso bo lekaneng ho re lumella ho fumana litaba; (3) boitsebiso ba ho ikopanya le uena, ho akarelletsa aterese ea hau, nomoro ea fono le aterese ea imeile; (4) polelo ea hau ea hore u na le tumelo e ntle ea hore litaba ka tsela e belaelloang ha e lumelloe ke mong'a litokelo tsa molao, kapa moemeli oa eona, kapa ka ts'ebetso ea molao leha e le ofe; "]
['(5) polelo e saennweng ke wena, tlasa kotlo ya ho hlapanya leshano, ya hore tlhahisoleseding e tsebisong e nepahetse le hore o na le matla a ho tiisa ditokelo tsa mongodi tseo ho thweng di a tlolwa; ']
["le (6) ho saena ka letsoho kapa ka elektronike ha mong'a litokelo tsa bangoli kapa motho ea lumeletsoeng ho nka khato lebitsong la mong'a litokelo tsa bangoli. "]
['Ho hloleha ho kenyelletsa tlhahisoleseding yohle e ka hodimo ho ka baka ho dieha ha ho sebetswa tletlebo ya hao.']
['Ho Iteanya']
['Ka kōpo re romelle imeile ka potso / tlhahiso leha e le efe.']
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Hoo e ka bang']
["BioMedLib e sebelisa lik'homphieutha tse iketsang (machine-learning algorithms) ho hlahisa lipotso le likarabo."]
['Re qala ka lingoliloeng tse limilione tse 35 tsa biomedical tsa PubMed/Medline. Hape, maqephe a websaete a RefinedWeb.']
